FDA Task Force on Nanotechnology
30 January 2007Nanomaterials are widely being used in various products as these nanomaterials have distinct properties than the parent materials. The properties differ not only in physical and chemical activities but in biological activity also. There are various drug and food categories where nanomaterials can find a useful contribution. Sometimes due to their different characteristics, these nanometerials may have an adverse affect on human health.
To study the biological affect of nanomaterials on humans, FDA (Food and Drug Administration of US) has recently announced formation of an internal task force group on nanotechnology. The task force will not only address the policy gaps but will also evaluate the possible side effects of various products that uses nanomaterials. The task force will also ensure to encourage the use of safe and effective nanomaterials used in various FDA regulated products. FDA will also continue to address various issues involved in the nanomaterial containing FDA regulated products on regular basis.
FDA will also assess the current scientific knowledge on nanomaterials and will also collaborate with other national agencies including Environmental Protection Agency (EPA), National Institute of Health (NIH) and Unites States Department of Agriculture (USDA). FDA will also get feedback from consumers, international agencies and other professionals from health and food industries. FDA will also develop the culture of developing superior nanomaterials that can be used for developing safe drugs.
Related Posts:
- New Research Grant for Heat Transfer Study
- Speeding up DNA sequencing
- Maxwell’s Demon: May the Force be With You
- Nano-Needles : Future LED’s and LED Laser
- Nanoscale silica behaves as ductile as gold
- Nanotechnology Promises Bone Cell Regeneration
- Nanodevices from conducting polymers
- Application of Nanotechnology in Electronic Devices
- Photonic Crystals from Colloids
- Nanoparticles: The Golden Bullet for Cancer Treatment
Top Of Page | Trackback
If you found this page useful, consider linking to it. Simply copy and paste the code below into your web site.
It will look like this: FDA Task Force on Nanotechnology